Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4basebio Plc Share News (4BB)

Share Price Information for 4basebio Plc (4BB)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
500.00
Ask:
550.00
Spread: 50.00 (10.00%)
Market Cap: £81.30m
4BB Live PriceLast checked at - London Stock Exchange

Intraday 4basebio Plc Share Chart

4basebio Plc News

4BaseBio expands facilities to support growing synthetic DNA demand
1 Apr 2026

4BaseBio expands facilities to support growing synthetic DNA demand

(Alliance News) - 4Basebio PLC on Tuesday said it is expanding to a new innovation hub and manufacturing facility at its headquarters in Cambridge, En...

IN BRIEF: 4basebio appoints Scott Lorimer as chief operating officer
12 Mar 2026

IN BRIEF: 4basebio appoints Scott Lorimer as chief operating officer

4basebio PLC - Cambridge, England-based life sciences company - Appoints Scott Lorimer as chief operating officer, with immediate effect. This follows...

4basebio promotes Christine Wolosin to chief commercial officer
9 Mar 2026

4basebio promotes Christine Wolosin to chief commercial officer

(Alliance News) - 4basebio PLC on Tuesday announced the promotion of Business Development Vice President Christine Wolosin to chief commercial officer...

4basebio promotes Christine Wolosin to commercial chief
3 Mar 2026

4basebio promotes Christine Wolosin to commercial chief

(Sharecast News) - 4basebio announced the promotion of Christine Wolosin to chief commercial officer on Tuesday, as the AIM-traded synthetic DNA speci...

4basebio promotes COO Amy Walker to CEO, CFO Roth to step down
10 Feb 2026

4basebio promotes COO Amy Walker to CEO, CFO Roth to step down

(Alliance News) - 4basebio PLC on Tuesday said it has promoted Chief Operating Officer Amy Walker to chief executive officer, succeeding founder Heikk...

4basebio says "tier one" partner tests vaccine from its template
27 Oct 2025

4basebio says "tier one" partner tests vaccine from its template

(Alliance News) - 4basebio PLC on Monday said its synthetic DNA product has been used in US clinical trials by a "global tier one" pharmaceutical part...

4basebio partner starts dosing patients in opDNA-based trial
27 Oct 2025

4basebio partner starts dosing patients in opDNA-based trial

(Sharecast News) - 4basebio said on Monday that a global tier-one pharmaceutical partner had started dosing patients in a phase one and two US clinica...

EARNINGS: Next 15 profit falls; 4basebio and Mollyroe losses widen
1 Oct 2025

EARNINGS: Next 15 profit falls; 4basebio and Mollyroe losses widen

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and Tuesday and not separately reported by All...